Drug Topics - March 10, 2008 - (Page 11) 11 Latebreakers due to flushing — the most commonly reported adverse effect of treatment with Simcor. According to Abbott, flushing can be minimized by taking aspirin or an NSAID 30 minutes prior to taking the medication at bedtime, and may subside over the course of several weeks of consistent treatment. Simcor will be available in three strengths (niacin/simvastatin): 500 mg/20 mg, 750 mg/20 mg, and 1000 mg/20mg. lecting signatures for The Prescription Benefit Management Administration Act that would amend state law to require that any Michigan citizen receiving a prescription drug benefit would be able to choose their pharmacy provider. The law would also require that copays and days’ supply for prescriptions be the same at all pharmacies. In order to be on the ballot, the initiative must have more than 300,000 signatures. gic rhinitis and for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children six years of age and older. The new product will offer an alternative to patients who cannot swallow the tablet form of the drug. During clinical trials, the most frequently occurring adverse reactions in adults and adolescents were somnolence, nasopharyngitis, fatigue, dry mouth, and pharyngitis. The new oral solution will be available in a concentration of 0.5 mg/mL and is contraindicated for patients with end-stage renal impairment with creatinine clearance less than 10 mL/min, patients undergoing hemodialysis, and pediatric patients aged six to 12 years with impaired renal function. DT Michigan PAC pushes back against PBMs A Michigan-based political action committee is hoping to get pharmacy benefit manager legislation on the November ballot in the state. The Captains of Pharmacy Political Action Committee is col- Antihistamine Xyzal now in oral solution Allergy sufferers taking levocetirizine (Xyzal, Sanofi-Aventis/UCB) may welcome a new formulation of the antihistamine. Levocetirizine oral solution is indicated for the relief of seasonal and perennial aller- http://www.fougera.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.